Biotech/Biomedical
News Category

SS Innovations CEO Outlines Growth Strategy as SSi Mantra Reaches 15,000 Procedures
SS Innovations International (NASDAQ: SSII) has performed over 15,000 robotic surgeries with its SSi Mantra system, including 750 cardiac procedures, ...

Quantum BioPharma Clarifies Share Consolidation Terms Ahead of Shareholder Meeting
Quantum BioPharma files a supplement to clarify share consolidation rounding and voting power caps, aiming to ensure a smooth shareholder vote on Nove...

Boston Symposium to Probe Human Egg Activation, a Frontier in Reproductive Science
Leading scientists will gather in Boston for the 2026 Activated Egg Symposium to address fundamental questions about how human eggs activate, with imp...

MEDICLIN Posts Higher Nine-Month Operating Result and EBIT, Confirms Full-Year Forecast
MEDICLIN increased its group operating result by 4.1% to EUR 585.9 million and EBIT by 7.8% to EUR 52.7 million in the first nine months of 2026, conf...

SS Innovations' 195 Telesurgeries Signal New Era in Remote Robotic Care
SS Innovations International has completed 195 telerobotic surgeries using its SSi Mantra system, demonstrating the commercial viability of remote sur...

Quantum BioPharma Targets Unmet Neurological Needs with Diversified Strategy
Quantum BioPharma is advancing a multi-pronged strategy that combines drug development, consumer wellness, and royalty partnerships to address neurolo...

Earth Science Tech Leverages Real Estate Subsidiary to Drive Long-Term Value
Earth Science Tech Inc. is integrating its real estate and asset management subsidiary, Avenvi LLC, to support its healthcare operations and generate ...

German Court Upholds Cancellation of CeramTec's Pink Trademark, Bolstering CoorsTek Bioceramics
A German federal court's ruling that CeramTec's pink trademark for ceramic hip components was filed in bad faith strengthens CoorsTek Bioceramics' com...

Annovis Bio's $21 Million Offering to Fund Buntanetap Trials in Alzheimer's and Parkinson's
Annovis Bio has priced a $21 million public offering to advance clinical development of its oral therapy buntanetap for Alzheimer's and Parkinson's di...

Kairos Pharma's ENV-105 Wins 2026 Biotech Breakthrough Award for Cancer Immunology
Kairos Pharma received the 2026 Biotech Breakthrough Award for its investigational therapy ENV-105, which aims to overcome treatment resistance in met...

Scinai Immunotherapeutics Reports 167% Revenue Growth and $8.32 Million in Committed Customer Orders
Scinai Immunotherapeutics posted 167% revenue growth to $2.8 million for the nine months ended Sept. 30, 2026, driven by CDMO expansion, and reported ...

Annovis Bio's Proposed Public Offering to Fund Buntanetap Clinical Development for Alzheimer's and Parkinson's
Annovis Bio's proposed public offering aims to raise capital to advance its lead drug candidate buntanetap through Phase 3 trials for Alzheimer's and ...

BioUtah to Honor Life Sciences Leaders at 2026 Awards Summit
BioUtah will present five Life Sciences Awards at the 2026 Utah Life Sciences Summit on November 11, recognizing leaders, innovators, and companies dr...

Pflugerville's Strategic Shift: How Advanced Manufacturing and a 'Fit-Over-Force' Approach Are Reshaping Austin's Suburb
Pflugerville's deliberate, people-first economic development strategy is attracting semiconductor, aerospace, and life sciences investment, offering a...

UNLOCKD Outlines Ancient Extracts UK Growth Strategy Following Binding LOI
UNLOCKD's proposed acquisition of Ancient Extracts UK would combine a profitable, subscription-based UK wellness business with its U.S. operations, po...

Phyllanthus urinaria Extract Shows Multi-Pathway Protection Against Cisplatin-Induced Kidney Injury in Mice
A mouse study finds that an aqueous extract of Phyllanthus urinaria L reduces cisplatin-induced acute kidney injury by curbing inflammation, apoptosis...

Biohackers World Miami Summit Signals Shift from Reactive Healthcare to Proactive Human Optimization
The Biohackers World Conference and Expo in Miami on January 16-17, 2027, marks the mainstreaming of human optimization, uniting over 2,000 attendees ...

Lonza CEO to Present at Jefferies Global Healthcare Conference
Lonza CEO Wolfgang Wienand will present at the Jefferies Global Healthcare Conference in London, offering investors a live webcast and replay of the s...

Viromed Medical AG Secures Early Approval for ViroCAP® med in Turkey, Accelerating International Expansion
Viromed Medical AG has received approval for its ViroCAP® med cold plasma device in Turkey ahead of schedule, with binding orders for 7,000 units thro...

Heidelberg Pharma to Present New Clinical Data on ATAC Candidates at ASH 2026
Heidelberg Pharma will present new clinical data on its ATAC candidates, pamlectabart tismanitin (HDP-101) and HDP-102, at the 68th ASH Annual Meeting...

Adaptogenics Positions for Peptide Market Shift as Federal Policy Opens Pharmacy and Telehealth Channels
Adaptogenics Health Corp. is positioning itself to capitalize on a proposed federal interim peptide access policy that could open specialty pharmacy a...

Tonix Pharmaceuticals to Present at Guggenheim Healthcare Innovation Conference, Spotlighting CNS and Immunology Pipeline
Tonix Pharmaceuticals' upcoming presentation at the Guggenheim Healthcare Innovation Conference highlights its commercial-stage CNS portfolio, includi...

Quantum BioPharma Targets Neurological Disorders with Diversified Strategy
Quantum BioPharma advances a broad strategy combining drug development, consumer wellness, and royalty partnerships to address the massive unmet need ...

Wellness Index Report Spotlights Three 'Builders of Healthspan' Shifting Aging from Chance to Engineering
The October 2026 Wellness Index Report highlights three experts who are reframing aging as a programmable, measurable process, signaling a broader shi...

Wellness Index Report Spotlights Three Experts Engineering Healthspan
The October 2026 Wellness Index Report highlights three experts who are shifting the focus from merely extending lifespan to engineering healthspan, w...

New Expert Consensus Standardizes Surgical Care for Wilms Tumor
A new expert consensus published in World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical decision-making for unilate...

Election Anxiety and AI Spending Panic Rattle Markets on Voting Day
As U.S. voters head to the polls, DH Unplugged episode 823 warns that a Democratic blue wave could trigger impeachment gridlock and a credibility cris...

CK Life Sciences' Sequencio to Present Promising Preclinical Cancer Vaccine Data at SITC 2026
Sequencio Therapeutics will present new preclinical data at SITC 2026 showing its lead cancer vaccine candidates generated targeted immune responses a...

Placebo-Controlled Trial of Quantum BioPharma's unbuzzd Draws Men's Fitness Scrutiny as Sector Eyes Evidence Standards
Quantum BioPharma's unbuzzd supplement, which showed significantly lower estimated blood alcohol concentration and improved alertness versus placebo i...

Helus Pharma CEO to Present at Guggenheim Healthcare Innovation Conference
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference on November 9, 2026, provid...

Kairos Pharma's ENV-105 Shows Significant Survival Benefit in Prostate Cancer Trial
Kairos Pharma's ENV-105 doubled median progression-free survival in metastatic castration-resistant prostate cancer, potentially overcoming treatment ...

Ultrasound Method for Brain Cancer Treatment Signals New Frontier in Drug Delivery
University of Virginia researchers have developed an experimental ultrasound-based technique to deliver therapeutic nanoparticles into the brain to fi...

HeartBeam Sets Q3 2026 Earnings Call, Spotlight on ALIGN-ACS Data and Heart Attack Detection Milestones
HeartBeam will host its Q3 2026 financial results call on Nov. 12, 2026, where management will discuss recent achievements including ALIGN-ACS pilot s...

Earth Science Tech's Conglomerate Model Delivers Built-In Operating Leverage
Earth Science Tech's diversified conglomerate model allows it to capture profit margins at every step of the healthcare value chain, from ingredient s...

Stroke Neurologist Bruce Ovbiagele to Receive 2026 Eugene Braunwald Academic Mentorship Award
The American Heart Association honors Dr. Bruce Ovbiagele with the 2026 Eugene Braunwald Academic Mentorship Award for his exceptional mentoring of ca...

New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer
A new expert consensus published in World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical management of unilateral Wi...

SS Innovations Demonstrates Transcontinental Robotic Cardiac Surgery, Advancing Remote Care Potential
SS Innovations showcased its SSi Mantra system by performing a robotic-assisted cardiac procedure from 7,500 miles away, highlighting the potential to...

Adaptogenics Health Corp. Targets Supply, Verification, Traceability in Emerging Peptide Market
Adaptogenics Health Corp. is building its peptide strategy around supply verification and traceability as the FDA and HHS move toward a regulated pept...

Quantum BioPharma's Unbuzzd Gains Men's Fitness Attention as Trial Shows Early Promise
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, has drawn praise from Men's Fitness after a clinical trial showed prom...

HeartBeam's ALIGN-ACS Pilot Data Signal Potential Shift in Remote Heart Attack Assessment
HeartBeam's ALIGN-ACS pilot study showed its portable ECG technology achieved higher specificity and comparable sensitivity to standard ECGs for acute...

Mayo Clinic Study Finds Brain Tumor DNA in Cerebrospinal Fluid, Opening Path to Less Invasive Diagnostics
A Mayo Clinic study has found that cerebrospinal fluid contains DNA from complex brain tumors, potentially enabling less invasive diagnosis and monito...

ABVC BioPharma Closes $3.39 Million Private Placement to Fund Operations and Settle Lind Global Claim
ABVC BioPharma's $3.39 million private placement of original issue discount convertible notes provides working capital and funds a $625,000 settlement...

tZERO to Go Public via SPAC Merger with FG Imperii, Valuing Tokenization Infrastructure Firm at $350 Million
tZERO's planned merger with FG Imperii Acquisition Corp. will take the tokenization infrastructure provider public at a $350 million pre-money valuati...

Long-Term Study Finds Modern Hormone Replacement Therapy Not Linked to Heart Disease Risk
A large Israeli study of over 52,000 women suggests that contemporary hormone replacement therapy does not increase cardiovascular risk for women aged...

Tonix Pharmaceuticals Appoints George Lederman as EVP of Strategy and Transformation to Lead AI and Business Development
Tonix Pharmaceuticals appoints George Lederman as EVP of Strategy and Transformation, tasking him with leading AI initiatives and business development...

AI and Wearables Predict Hypertensive Crisis Up to 3 Days Early
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 shows that AI analysis of data from a portable blood press...

Okogen Doses First Patient in EMERALD Trial, Advancing Treyegen Toward a New Treatment Approach for Acute Infectious Conjunctivitis
Okogen has dosed the first patient in its Phase 1/2 EMERALD trial of Treyegen for acute infectious conjunctivitis, a milestone that could validate its...
